Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. Santini

Intranodal Treatment With Ifnα-Dendritic Cells and Rituximab Induces Systemic Clinical Response and Endogenous Vaccination Against Follicular Lymphoma: Final Result of a Phase I Study

Hematological Oncology

English

Severe Hemoperitoneum After Patient Self-Induced Fecal Evacuation

Case Reports in Medicine

Medicine

2011

English

Related publications

Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma

British Journal of Haematology

Hematology

2018

English

Vaccination With Bordetella Pertussis-Pulsed Autologous or Heterologous Dendritic Cells Induces a Mucosal Antibody Response in Vivo and Protects Against Infection

Infection and Immunity

English

A Phase II Study of Bendamustine in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-Follicular Non-Hodgkin Lymphoma

Leukemia and Lymphoma

English

Lactate Dehydrogenase-Elevating Virus Induces Systemic Lymphocyte Activation via TLR7-Dependent IFNα Responses by Plasmacytoid Dendritic Cells

PLoS ONE

Multidisciplinary

2009

English

Follicular Dendritic Cells in Follicular Lymphoma and Types of Non-Hodgkin Lymphoma Show Reduced Expression of CD23, CD35 and CD54 but No Association With Clinical Outcome

English

A Retrospective Study on the Management of Patients With Rituximab Refractory Follicular Lymphoma

British Journal of Haematology

Hematology

2017

English

Results of Phase Ii Study of Combined Immunotherapy With Rituximab Plus Lymphokine-Activated Killer Cells as Maintenance in Follicular Lymphoma Patients

Hematological Oncology

English

Bendamustine and Rituximab in Elderly Patients With Low-Tumour Burden Follicular Lymphoma. Results of the LYSA Phase II BRIEF Study

British Journal of Haematology

Hematology

2018

English

A Phase I/Ii Study of Rituximab and Etanercept in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. Santini

Intranodal Treatment With Ifnα-Dendritic Cells and Rituximab Induces Systemic Clinical Response and Endogenous Vaccination Against Follicular Lymphoma: Final Result of a Phase I Study

Severe Hemoperitoneum After Patient Self-Induced Fecal Evacuation

Related publications

Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma

Vaccination With Bordetella Pertussis-Pulsed Autologous or Heterologous Dendritic Cells Induces a Mucosal Antibody Response in Vivo and Protects Against Infection

A Phase II Study of Bendamustine in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-Follicular Non-Hodgkin Lymphoma

Lactate Dehydrogenase-Elevating Virus Induces Systemic Lymphocyte Activation via TLR7-Dependent IFNα Responses by Plasmacytoid Dendritic Cells

Follicular Dendritic Cells in Follicular Lymphoma and Types of Non-Hodgkin Lymphoma Show Reduced Expression of CD23, CD35 and CD54 but No Association With Clinical Outcome

A Retrospective Study on the Management of Patients With Rituximab Refractory Follicular Lymphoma

Results of Phase Ii Study of Combined Immunotherapy With Rituximab Plus Lymphokine-Activated Killer Cells as Maintenance in Follicular Lymphoma Patients

Bendamustine and Rituximab in Elderly Patients With Low-Tumour Burden Follicular Lymphoma. Results of the LYSA Phase II BRIEF Study

A Phase I/Ii Study of Rituximab and Etanercept in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma